Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort

INTRODUCTION: Recent studies have introduced elevated lipoprotein(a) (Lp(a)) as a risk factor for coronary heart disease (CHD). This study investigated whether the addition of Lp(a) as a novel biomarker to the Framingham Risk Score (FRS) model improves CHD risk prediction. METHODS: The study include...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghavami, Mojgan, Abdshah, Alireza, Esteghamati, Sadaf, Hafezi-Nejad, Nima, Nakhjavani, Manouchehr, Esteghamati, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693688/
https://www.ncbi.nlm.nih.gov/pubmed/38042772
http://dx.doi.org/10.1186/s12889-023-17332-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693688/
https://www.ncbi.nlm.nih.gov/pubmed/38042772
http://dx.doi.org/10.1186/s12889-023-17332-w

Ejemplares similares